Efficacy of pazufloxacin mesilate in Legionnaires' disease: A case report and in vitro study of the isolate

Journal of Infection and Chemotherapy

Volumn 11, Issue 3, 2005, Pages 164-168

  Higa, Futoshi ^a   Shinzato, Takashi ^a   Toyama, Masato ^a   Haranaga, Shusaku ^a   Furugen, Makoto ^a   Tateyama, Masao ^a   Kawakami, Kazuyoshi ^a   Saito, Atsushi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Fluoroquinolone; Legionella pneumophila; Legionnaires' disease; Pazufloxacin mesilate

Indexed keywords

BACTERIAL ANTIGEN; LEVOFLOXACIN; PAZUFLOXACIN;

ADULT; ANAMNESIS; ARTICLE; BACTERIUM ISOLATE; CASE REPORT; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; DRUG ACTIVITY; DRUG EFFICACY; HUMAN; IN VITRO STUDY; LABORATORY TEST; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; LUNG LAVAGE; MALE; MINIMUM INHIBITORY CONCENTRATION; PHYSICAL EXAMINATION;

EID: 21644443070     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-005-0381-3     Document Type: Article

References (21)

1. TJ Marrie H Durant L Yates 1989 Community-acquired pneumonia requiring hospitalization: 5-year prospective study Rev Infect Dis 11 586 99
2. RD Meyer PH Edelstein BD Kirby MH Louie ME Mulligan AA Morgenstein 1980 Legionnaires' disease: unusual clinical and laboratory features Ann Intern Med 93 240 3
3. TW Nash DM Libby MA Horwitz 1984 Interaction between the Legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages: influence of antibody, lymphokines, and hydrocortisone J Clin Invest 74 771 82
4. CH Mody R Paine 3rd MS Shahrabadi RH Simon E Pearlman BI Eisenstein 1993 Legionella pneumophila replicates within rat alveolar epithelial cells J Infect Dis 167 1138 45
5. DW Fraser TR Tsai W Orenstein WE Parkin HJ Beecham RG Sharrar 1977 Legionnaires' disease: description of an epidemic of pneumonia N Engl J Med 297 1189 97
6. PH Edelstein 1998 Antimicrobial chemotherapy for Legionnaires' disease: time for a change Ann Intern Med 129 328 30
7. T Muratani M Inoue S Mitsuhashi 1992 In vitro activity of T-3761, a new fluoroquinolone Antimicrob Agents Chemother 36 2293 303
8. Y Fukuoka Y Ikeda Y Yamashiro M Takahata Y Todo H Narita 1993 In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative Antimicrob Agents Chemother 37 384 92
9. Y Niki S Yoshida 2004 Successfully treatment of Legionella pneumonia with pazufloxacin mesilate. Kagaku ryoho no Ryouiki 20 611 3 (in Japanese)
10. F Higa N Arakaki M Tateyama M Koide T Shinzato K Kawakami 2003 In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp J Antimicrob Chemother 52 920 4
11. F Higa N Kusano M Tateyama T Shinzato N Arakaki K Kawakami 1998 Simplified quantitative assay system for measuring activities of drugs against intracellular Legionella pneumophila J Clin Microbiol 36 1392 8
12. CH Heath DI Grove DF Looke 1996 Delay in appropriate therapy of Legionella pneumonia associated with increased mortality Eur J Clin Microbiol Infect Dis 15 286 90
13. BS Fields RF Benson RE Besser 2002 Legionella and Legionnaires' disease: 25 years of investigation Clin Microbiol Rev 15 506 26
14. JH Helbig SA Uldum S Bernander PC Luck G Wewalka B Abraham 2003 Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial Legionnaires' disease J Clin Microbiol 41 838 40
15. P Flori B Bellete F Durand H Raberin C Cazorla J Hafid 2004 Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens J Med Microbiol 53 603 7
16. DK Heyland DJ Cook J Marshall M Heule B Guslits J Lang 1999 The clinical utility of invasive diagnostic techniques in the setting of ventilator- associated pneumonia; Canadian Critical Care Trials Group Chest 115 1076 84
17. WR Kohorst SA Schonfeld JE Macklin ME Whitcomb 1983 Rapid diagnosis of Legionnaires' disease by bronchoalveolar lavage Chest 84 186 90
18. PC Wever DW Notermans II Tulevski JK Schattenkerk MD de Jong 2003 Detection of Legionella pneumophila serogroup 1 antigen in bronchoalveolar lavage fluid by an immunochromatographic assay J Clin Microbiol 41 2265
19. M Nakashima K Uemura K Kosuge T Uematsu 1999 Phase I clinical study of pazufloxacin mesilate Jpn J Chemother 47 141 75 (in Japanese)
20. DH Wright GH Brown ML Peterson JC Rotschafer 2000 Application of fluoroquinolone pharmacodynamics J Antimicrob Chemother 46 669 83
21. J Azuma I Yamamoto Y Seto 1997 Phase I clinical study of ciprofloxacin Kiso to Rinsyo 31 2701 25 (in Japanese)